It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • HOME DELIVERY |
  • SUBSCRIBE |
  • Login
  • My Account
TODAY'S PRINT EDITION

The Japan Times The Japan Times

medicine

  • Login
  • SUBSCRIBE
  • My Account
  • HOME DELIVERY ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
China’s 60,000 COVID-19 death toll spurs calls for more data

Asia Pacific Jan 15, 2023

China’s 60,000 COVID-19 death toll spurs calls for more data

China COVID-19 surge since December has spurred concern about variants; WHO chief stresses importance of transparency.

Japan's Daiichi Sankyo applies for approval of mRNA COVID vaccine

Business Jan 13, 2023

Japan's Daiichi Sankyo applies for approval of mRNA COVID vaccine

An approval would give Japan a homegrown mRNA vaccine — a vaccine type that has played a dominant role in the country's COVID-19 inoculation drive to this point.

Health concerns, not pride, should guide COVID-19 travel policy

Editorials Jan 13, 2023

Health concerns, not pride, should guide COVID-19 travel policy

Apparently China can shut its borders to reduce the risk of COVID-19 infections, but Beijing doesn't think other countries should do the same.

Why the future of technology is so hard to predict

Commentary / World Jan 12, 2023

Why the future of technology is so hard to predict

by Faye Flam

It’s 2023, yet we’re not all riding Segways, having sex with robots or cloning humans. What gives?

Don't write off the retooled COVID-19 boosters

Commentary / World Jan 11, 2023

Don't write off the retooled COVID-19 boosters

by Lisa Jarvis

Two new studies claim the bivalent omicron shot is no better than the original vaccine. But there are important caveats.

Health ministry suggests restricting bulk drug purchases amid hoarding fears

National Jan 11, 2023

Health ministry suggests restricting bulk drug purchases amid hoarding fears

by Kanako Takahara

The message follows reports of Chinese people in the country buying medicine in bulk and mailing it to friends and families back home.

Eisai shares jump after FDA approves Alzheimer’s drug lecanemab

Business / Financial Markets Jan 10, 2023

Eisai shares jump after FDA approves Alzheimer’s drug lecanemab

by Kanoko Matsuyama

The drug, to be sold under the brand name Leqembi, was approved by the Food and Drug Administration under an accelerated pathway.

China’s COVID surge threatens villages as Lunar New Year approaches

Asia Pacific Jan 7, 2023

China’s COVID surge threatens villages as Lunar New Year approaches

by David Pierson, Joy Dong, Claire Fu and Olivia Wang

China is bracing for an onslaught of infections in its fragile countryside as millions of people crowd onto trains and buses to return to their rural homes for the Lunar New Year holiday.

China in talks with Pfizer for generic COVID drug

Asia Pacific / Science & Health Jan 7, 2023

China in talks with Pfizer for generic COVID drug

Beijing is in talks with the drugmaker to secure a license that will allow domestic firms to manufacture and distribute a generic version of its Paxlovid antiviral drug.

No, vaccines aren’t making new COVID-19 variants worse

Commentary / World Jan 6, 2023

No, vaccines aren’t making new COVID-19 variants worse

by Faye Flam

The omicron sequel XBB.1.5 is driving a new wave of COVID-19 infections — and misinformation.

Cancer vaccine hunt finally makes progress

Commentary / World Jan 4, 2023

Cancer vaccine hunt finally makes progress

by Lisa Jarvis

A small study shows promise in deploying mRNA technology against melanoma — but fighting tumors is vastly more complex than tackling COVID-19.

China's COVID wave sparks scramble for vital drugs across Asia

Asia Pacific Dec 30, 2022

China's COVID wave sparks scramble for vital drugs across Asia

by Jennifer Creery

Beijing’s decision to abruptly remove most pandemic restrictions with little preparation is driving an unprecedented number of cases, leaving hospitals and funeral homes overwhelmed.

« 1 … 7 8 9 … 46 »
  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Nadeshiko Japan downs Costa Rica to move into knockout stage

    Thumbnail image
  • AI is rewriting the rules of $200 billion games industry

    Thumbnail image
  • Indonesia rides EV rush to domestic IPO boom

    Thumbnail image
  • 'Japan's Anatolia' becomes a home away from home for Kurds and Turks

    Thumbnail image
  • From 'Young General' to 'Supreme Leader': The evolution of Kim Jong Un

    Thumbnail image

PODCAST

  • DEEP DIVE

    A tale of two Fujis: Bullet climbs, crowds and Lizzo

Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha JT Bookclub The Japan Times Jobs Education in Japan
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Work with us
  • Privacy Policy
  • Link policy
  • Republishing
  • FAQs
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times